Cargando…
The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus
The main protease (Mpro or 3CLpro) of SARS-CoV-2 virus is a cysteine enzyme critical for viral replication and transcription, thus indicating a potential target for antiviral therapy. A recent repurposing effort has identified ebselen, a multifunctional drug candidate as an inhibitor of Mpro. Our do...
Autores principales: | Qiao, Zhen, Wei, Ningning, Jin, Lin, Zhang, Hongyi, Luo, Jiajie, Zhang, Yanru, Wang, KeWei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556866/ https://www.ncbi.nlm.nih.gov/pubmed/34740055 http://dx.doi.org/10.1016/j.bioorg.2021.105455 |
Ejemplares similares
-
Studies on antiviral resistant SARS-CoV-2 Mpro mutants
por: Esler, Morgan A., et al.
Publicado: (2023) -
Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
por: Sun, Le-Yun, et al.
Publicado: (2021) -
Detection of Lipase Activity in Cells by a Fluorescent Probe Based on Formation of Self-Assembled Micelles
por: Qiao, Zhen, et al.
Publicado: (2020) -
De Novo design of potential inhibitors against SARS-CoV-2 Mpro
por: Li, Shimeng, et al.
Publicado: (2022) -
Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)